List of Tables
    Table 1. Daclatasvir CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Daclatasvir Market Trends
    Table 3. Daclatasvir Market Drivers
    Table 4. Daclatasvir Market Challenges
    Table 5. Daclatasvir Market Restraints
    Table 6. Global Daclatasvir Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Daclatasvir Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Daclatasvir Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Daclatasvir Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Daclatasvir Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Daclatasvir Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Daclatasvir Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Daclatasvir Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Daclatasvir Sales Share by Manufacturer, 2017-2022
    Table 15. Global Daclatasvir Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Daclatasvir Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Daclatasvir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daclatasvir as of 2021)
    Table 18. Top Players of Daclatasvir in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Daclatasvir Product Type
    Table 20. Date of International Manufacturers Enter into Daclatasvir Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Daclatasvir Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Daclatasvir Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Daclatasvir Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Daclatasvir Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Daclatasvir Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Daclatasvir Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Daclatasvir Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Daclatasvir Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Daclatasvir Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Daclatasvir Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Daclatasvir Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Daclatasvir Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Daclatasvir Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Daclatasvir Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Daclatasvir Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Daclatasvir Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Daclatasvir Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Daclatasvir Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Daclatasvir Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Daclatasvir Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bristol-Myers Squibb Corporation Information
    Table 43. Bristol-Myers Squibb Description and Business Overview
    Table 44. Bristol-Myers Squibb Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Bristol-Myers Squibb Daclatasvir Product
    Table 46. Bristol-Myers Squibb Recent Development
    Table 47. Natco Pharma Corporation Information
    Table 48. Natco Pharma Description and Business Overview
    Table 49. Natco Pharma Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Natco Pharma Product
    Table 51. Natco Pharma Recent Development
    Table 52. Zydus Cadila Corporation Information
    Table 53. Zydus Cadila Description and Business Overview
    Table 54. Zydus Cadila Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Zydus Cadila Product
    Table 56. Zydus Cadila Recent Development
    Table 57. Hetero Drugs Corporation Information
    Table 58. Hetero Drugs Description and Business Overview
    Table 59. Hetero Drugs Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Hetero Drugs Product
    Table 61. Hetero Drugs Recent Development
    Table 62. Dr Reddy's Laboratories Corporation Information
    Table 63. Dr Reddy's Laboratories Description and Business Overview
    Table 64. Dr Reddy's Laboratories Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Dr Reddy's Laboratories Product
    Table 66. Dr Reddy's Laboratories Recent Development
    Table 67. Cipla Corporation Information
    Table 68. Cipla Description and Business Overview
    Table 69. Cipla Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Cipla Product
    Table 71. Cipla Recent Development
    Table 72. Mylan Corporation Information
    Table 73. Mylan Description and Business Overview
    Table 74. Mylan Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Mylan Product
    Table 76. Mylan Recent Development
    Table 77. Abbott Corporation Information
    Table 78. Abbott Description and Business Overview
    Table 79. Abbott Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Abbott Product
    Table 81. Abbott Recent Development
    Table 82. Emcure Pharmaceuticals Corporation Information
    Table 83. Emcure Pharmaceuticals Description and Business Overview
    Table 84. Emcure Pharmaceuticals Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Emcure Pharmaceuticals Product
    Table 86. Emcure Pharmaceuticals Recent Development
    Table 87. Torrent Pharmaceuticals Corporation Information
    Table 88. Torrent Pharmaceuticals Description and Business Overview
    Table 89. Torrent Pharmaceuticals Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Torrent Pharmaceuticals Product
    Table 91. Torrent Pharmaceuticals Recent Development
    Table 92. Biocon Corporation Information
    Table 93. Biocon Description and Business Overview
    Table 94. Biocon Daclatasvir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Biocon Product
    Table 96. Biocon Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Daclatasvir Customers List
    Table 100. Daclatasvir Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Daclatasvir Product Picture
    Figure 2. Global Daclatasvir Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Daclatasvir Market Size 2017-2028 (US$ Million)
    Figure 4. Global Daclatasvir Sales 2017-2028 (K Pcs)
    Figure 5. United States Daclatasvir Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Daclatasvir Market Size 2017-2028 (US$ Million)
    Figure 7. United States Daclatasvir Sales 2017-2028 (K Pcs)
    Figure 8. United States Daclatasvir Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Daclatasvir Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Daclatasvir Report Years Considered
    Figure 11. Product Picture of 30mg Tables
    Figure 12. Product Picture of 60mg Tables
    Figure 13. Global Daclatasvir Market Share by Type in 2022 & 2028
    Figure 14. Global Daclatasvir Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Daclatasvir Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Daclatasvir Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Daclatasvir Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Daclatasvir Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Daclatasvir Market Share by Type in 2022 & 2028
    Figure 20. United States Daclatasvir Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Daclatasvir Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Daclatasvir Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Daclatasvir Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Daclatasvir Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Hepatitis C Virus (HCV) Genotype 1
    Figure 26. Product Picture of Hepatitis C Virus (HCV) Genotype 3
    Figure 27. Product Picture of Hepatitis C Virus (HCV) Genotype 4
    Figure 28. Global Daclatasvir Market Share by Application in 2022 & 2028
    Figure 29. Global Daclatasvir Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Daclatasvir Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Daclatasvir Sales by Application (2017-2028) & (K Pcs)
    Figure 32. Global Daclatasvir Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Daclatasvir Price by Application (2017-2028) & (USD/Pcs)
    Figure 34. United States Daclatasvir Market Share by Application in 2022 & 2028
    Figure 35. United States Daclatasvir Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Daclatasvir Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Daclatasvir Sales by Application (2017-2028) & (K Pcs)
    Figure 38. United States Daclatasvir Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Daclatasvir Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. North America Daclatasvir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 41. North America Daclatasvir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Daclatasvir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 45. Europe Daclatasvir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Daclatasvir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 52. Asia-Pacific Daclatasvir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Daclatasvir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 64. Latin America Daclatasvir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Daclatasvir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Middle East & Africa Daclatasvir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Daclatasvir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Daclatasvir Value Chain
    Figure 74. Daclatasvir Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed